This leading and unique gathering of pharma and biotech regulatory, in-house counsel and private practice specialists will discuss the updates and strategies concerning SPCs and PTEs. Attend and update your life science exclusivity strategy for 2024.
CLICK HERE TO REGISTER YOUR INTEREST
Highlights for include:
- SPC Waiver Litigation Update and its Impact on the Generic and Innovator Landscape.
- CJEU opinion for C-119/22 and C-149/22.
- An update on the Unitary SPC proposal and how to update your European patenting strategy.
- SPCs 101- What every patent practitioner needs to know about SPCs.
